boston745
6 hours ago
To add to my post about NP Aerospace, here is this part from Tuesdays Press Release.
Other proprietary technologies include the manufacture of high performance, lower cost ballistic materials for opaque armor applications at its subsidiary, SINTX Armor. SINTX Armor is expected to begin production of a competitively priced body- and vehicle-protective armor product that has undergone successful testing.
This was likely what Sintx and NP Aerospace have been waiting for in regards to some sort of announcement between the two.
========================================
To your so called deflections Joe, my last post specifically indicated that i participated in shareholder rights offering and ive said as much since the 2022 offering. To do so i had to be a shareholder already. I added it after posting that post during the 15min edit window and added it to the wrong paragraph; maybe you just missed it.
Participating in shareholder rights offerings is one way and what i have done.
One thing that would help Sintx/SINT proper valuation is an end to the short and distort campaign thats been waged here for 9 years. It is a fact that there has been extensive shorting and distorting here. Its insanely obvious between the 2022 RS and the 2023 RS with the extent of naked shorting. Every offering over that time included known shorting and distorting fund Anson Group with its family of funds coupled with 50% price declines before and after the offerings. These facts, detailed below.
Another thing that would help with Sintx valuation is management & other Sintx employees finally buying shares after a new shareholder plan is voted on this year. They deserve to reap the rewards of their labor when all those products begin to see the light of day. That coupled with major tutes taking positions. Then for the price to really take off, finally the public announcement of Sintx partnership with Zimmer Biomet as well as partnerships with Solventum & Cardinal Health all with some degree of guidance as to when these strategic partnerships will bring products in the Ortho, PPE, & Catheter industries to market. A sale of Armor division or NP Aerospace partnership certainly wouldnt hurt!
As Sonny is a medical and material research scientist, new CEO to help guide Sintx through all that is a good idea. So him stepping down is the right move if this is going to play out something like i just laid out.
========================================
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years. A conspiracy of shorting and distorting.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174597546
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174599544
I go into some of the evidence of this in the February 2023 offering where they drove the price up & naked shorted it down. Ansons family of funds participated in every offering in 2023 up to the recent RS. Anson and the other funds its associated with are known for their short and distort actvity and are under investigation by the DOJ. SEC slapped it with a ticket fine basically that will in no way discourage its shorting and distorting methods.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174602472
Look at this dated chart and you can see that SINT had been trading in a downward channel but in 2022 price manipulation went to a new level with 50% drops in price before and after each offering. All the while Sintx revenue has been growing as well as its list of collaborations with the military and in the aerospace markets.
https://i.imgur.com/xMRDE8n.jpeg
boston745
9 hours ago
In regards to this weeks press release, i hope its indication that one of their strategic partners is going to take a stake in the company. Either that or that they will sell the armor division to NP Aerospace.
SINTX Technologies to Explore Strategic Opportunities
https://ir.sintx.com/news-events/press-releases/detail/233/sintx-technologies-to-explore-strategic-opportunities
NP Aerospace needs a US based manufacturing plant and it uses the exact armor materials that Sintx Armor provides. Donald Bray, Consultant/former VP at Sintx & Morgan Ceramics, oversaw NP Aerospace division before it was divested Nov 2018. 6 months later he was hired at Sintx, April 2019 (6 month non-compete?). This suggests one of the reasons he was brought on, possibly sent, to Sintx was to help Sintx receive ISO 9001 certified facilities so it could produce goods for defense and aerospace applications. IE, supply Morgan Ceramics in Aerospace and NP Aerospace in armor. Morgan Ceramics has been a strategic partner of Sintx since 2016.
NP Aerospace currently has manufacturing locations in England and Canada with only a sales presence in Florida. It could either acquire Sintx armor or simply setup a joint venture. US represents a significant market of interest and target for expansion for NP.
Non-compete
Most states follow the doctrine of “equitable reformation," which enables contracts to be upheld with revisions. For example, a contract that originally lasted five years after an employee's termination may be amended to last for only six months with all other provisions in place.
From NP Aerospace Patent
The outer ceramic armour layer 2 may be segmented armour and may comprise tiles or pellets of ceramic and the ceramic may be of any ballistically suitable type, including without limitation; alumina, silicon carbide, boron carbide, and composite ceramics. Typically the thickness is greater than 4 mm, but thickness depends on threat level.
Sintx Armor currently produces products out of boron carbide and silicon carbide/boron carbide ceramics called Boroshock & Durashock: https://sintx.com/applications/ceramic-armor/
The expansions we are forecasted to see in 2022 are likely to open up some opportunities for us in the long term, to do some really strategic acquisitions in key markets, which in turn will act as a catalyst for faster growth in certain regions. That potential is certainly there for us in the US, which is very exciting,” James concludes.
Quote source:
https://www.freepatentsonline.com/9846013.html
https://manufacturing-today.com/news/np-aerospace/
https://www.legalzoom.com/articles/noncompete-agreements-explained
https://i.imgur.com/slfDxL5.jpeg
https://web.archive.org/web/20221128231656/https://static.seekingalpha.com/uploads/sa_presentations/787/14787/original.pdf
========================================
As you can see Joev2 continues to employ techniques of disinformation in his posts:
https://web.archive.org/web/20231004223836/https://www.ethosdebate.com/lies-rhetoric-4-18-rules-disinformation/
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
List of Markets Sintx can participate in and products in development:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174489883
========================================
Sintx valuation should be greater than $230m based on comparable company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174491281
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
joev2
9 hours ago
Deflect, deflect, deflect....
Deflection A) Folks, notice there's no comment as to personal involvement in a losing investment, ongoing year after year, yet there remains a continual flow of support for management and supposed value. Why?
Deflection B) attention is drawn to company's alleged billion dollar+ value but NO explanation as to how it can possibly get there under present circumstances i.e. reverse splits, dilution and management being in bed with the vulture crowd all the time.
Deflection C) The usual accusations of distorting and shorting, while ignoring truths as to why the company is and remains in the position it's in, along with the FACT that WHEN investors DO SHORT continually at such a high percentage (as is the case here) they do it because NO ONE CONSIDERS the company a worthwhile investment. This he considers a collusive distort and short campaign.
Truth is folks, people and institutions are just using common sense. If an investor sees a company that's crap, they either ignore it (institutions) or short it (professional shorters and gamers). Showing the smallest of interest as is mentioned frequently here, is nothing more than throwing a buck down on a lottery ticket. Real issue here (always ignored) is WHY doesn't ANYONE invest? Literally NO ONE invests here. That is the point a 'true' believer and investor would want addressed, but would never be by a paid shill. Instead we get accusations and innuendos directed at those who are simply pointing out the obvious. Talk about a distortion campaign lol......
NO ONE WANTS SINT! NO ONE BELIEVES SINT or IN SINT. From management to institutions to accredited lenders to individuals....NO ONE sees true value here and so purported value is made up by an individual based on the purchases of lottery tickets by powerhouse institutions and the like.
boston745
12 hours ago
Im not going to get pulled into an attempt to create more forum verbiage to drown out good information. Plus im limited to 3 posts a day for going on 9 months now. Yes you've employed a lot of methods of disinformation in your posts. Like TA over on ST, youre good at projecting things you yourself are doing.
When i commented that youve been here for 8 years it means you should know a thing or two about the markets Sintx can participate in. Thus you could give some insight if you wanted as to the potential/value of Sintx Intellectual Property. The fact that you do not want to...is telling. It means you do not want to incriminate yourself or arm me if you agreed; although your original 1-10b spread maybe your attempt at an honest answer. 50b is ridiculous which is likely why you are ok with me saying you believe that. $270m has been spent developing Sintx IP over the years and thus $1.2b represents a decent ROI on that. 10x return would be 2.7b which is about 1% of Sintx addressable markets. However because SINT is so undervalued, those funds can buy super cheap and make back shareholder investment that way allowing SIntx to be acquired for far less than its IP is worth. It'll be interesting if this is how things play out... Still 270m is tax credit offset representing a sizable credit to potential acquiring company. Sintx has a superior/disruptive product that can sell into very large markets and no debt. Thats extremely rare to find at a company worth so little. Thus investors need to protect their investment. Participating in shareholder rights offerings is one way and what i have done.
I completely acknowledge that there is no tute with a large stake in Sintx. This part has evidence supporting it. Having said that, the fact that major funds, mostly connected to Zimmer Biomet, have had small stakes in Sintx for pretty much the entire time we've been here, does not suggest lack of interest as you like to imply. It suggests they are keeping an eye on Sintx but something holds them back (most important funds are Blackrock and Wells Fargo as both are major investors of Zimmer & Biomet before merger). While those funds have been in the background, SINT has been under a short and distort campaign for 9 years now, proof below. As long as those funds & management stay in the background, this short and distort campaign seems likely to continue.
Heres 4 markets Sintx can participate in to give an idea of potential worth. Mind you Sintx can play in more markets than this:
Global Ortho device market = $64bn by 2025
Global Catheter market = $55bn in 2023
Personal Protective Equipment market = $79.53 billion
Antibacterial market = $44.5bn 2024
Right there thats a maximum of $243bn in just 4 markets. This doesnt include Dental implant market, Wound Care market, Oncology market via Cancer treatment applications and so many other markets Sintx could participate in. Hell im surprised Musks Neuralink hasnt tapped Sintx as the material would help with implantation both in reducing infection as well as reducing toxic corrosion.
People may look at this and think its ridiculous because Sintx is worth like 4.2m but its material is destined to replace current biomaterials in the ortho market. Its antiviral, antibacterial, antifungal so great product for catheter and PPE markets. Assuming it can be imbued in soap solutions obviously it would be great for the antibacterial markets as well. Its shows effectiveness against all ss-RNA viruses including Bird Flu & Covid. As well as they found its effective against herpes which is a double stranded DNA virus meaning it could be effective for the 10b condom market to help slow the spread of STIs.
Instantaneous Inactivation of Herpes Simplex Virus by Silicon Nitride Bioceramics
https://www.mdpi.com/1422-0067/24/16/12657
Funds watching Sintx:
https://fintel.io/so/us/sint
My post on markets Sintx can participate in with valuations and evidence:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174624826
Proof of short and distort campaign being waged against Sintx/SINT below.
Methods of Disinformation commonly being used in posts that are overly negative on Sintx. If those posting overly negative posts against Sintx were right, they wouldnt need to use disinformation tactics. They could just stick to the facts. They lack substance outside of things they can manipulate via the markets.
https://web.archive.org/web/20231004223836/https://www.ethosdebate.com/lies-rhetoric-4-18-rules-disinformation/
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years. A conspiracy of shorting and distorting.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174597546
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174599544
I go into some of the evidence of this in the February 2023 offering where they drove the price up & naked shorted it down. Ansons family of funds participated in every offering in 2023 up to the recent RS. Anson and the other funds its associated with are known for their short and distort actvity and are under investigation by the DOJ. SEC slapped it with a ticket fine basically that will in no way discourage its shorting and distorting methods.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174602472
joev2
1 day ago
TA I don't know if this individual is a compensated shill or not, but if he isn't, he's most definitely the most stubborn, arrogant individual I've ever had a back and forth with on these boards. I've yet to hear him admit true wrong by himself or the company. Constant deflection along with the aim to steer the narrative in only one direction is his forte'. I'm sure the PERSONAL content of a post such as this, will be what he ONLY addresses, along with the other 17... Oh, and of course Bal's success and Sint's true worth....apparently missed by just...everybody else... LOL.
Hey Boston, would you care to divulge how much you have invested here, lost, or are willing to invest further? Seems kind of strange with all the accusations and innuendos from your side towards those opposing your views, that I have yet to see any numbers of anything invested coming from your end. Gives credence to the shill pov, imo.
joev2
1 day ago
Like I've said, you deflect, deflect, deflect. You have no interest in discussion, only in people agreeing with your views. I don't and won't because Sint remains a loser based on tons and tons of evidence that you willfully ignore. I have zero interest in delving deeper and deeper into doo-doo, okay? It makes no difference to me whatsoever (as I've stated many times) what Sint is or isn't intrinsically worth. So feel free to tell people I believe Sint is worth 50 billion. I don't care! Maybe it's true as well, okay?
Whether or not Bal got in bed with the wrong people on purpose or by ignorance and naivety (You'd be surprised how many startup ceos are ignorant of the vultures that surround them), the truth is he did and the results are the same for virtually every company which has done the same: a never ending death spiral. THAT is a FACT you continually and willfully ignore. And so you keep trying to rope people like myself into agreeing what a great company Sint is or will be or should be. No one listens or agrees. Doesn't matter what you say they SHOULD be worth.
They blew their chances long ago when they (for whatever reason) got into the death spiral routine thanks to the likes of Maxim and similar. And here they are, and here you are....longer than my eight years, but still spouting the same stuff that has gotten you nowhere, the company nowhere and the investment community nowhere. However, I'm sure some are travelling much lighter these days, thanks to their following your advice and/ or believing in Bal's leadership abilities.
Now feel free to once again post how I'm using disinfo tactics, personal attacks or posting negative stuff. Truth is, there's hardly a thing that isn't negative about Sint, including the alleged positives that are anything but, to the investor. Ask Bal. His supposed 1 million entry early on, leads me to believe he was duped by the Ascendiant and Maxim types (like many CEOs are) but to his credit, he has since learned. However, his disdain for fellow investors hasn't exactly endeared him, nor has his rewarding himself with bonuses for performance which is nothing short of horrendous (except to you). Enjoy ranting on my friend. I'll still probably respond in some fashion because I don't enjoy people losing their money (unless they refuse not to).
boston745
1 day ago
You've been posting here for about 8 years and have claimed to have invested in several stocks through the years. I think you can do better than I dont know. I dont know is the same as saying no comment without actually saying no comment which is a more evasive answer. A more honest answer would have been to say that you could see scenarios where its worth over 1 billion with the right commercialization partners. We both know Sintx depends on strategic partnerships for commercialization purposes.
Lets look at 4 markets Sintx can participate in to give an idea of potential worth. Mind you Sintx can play in more markets than this:
Global Ortho device market = $64bn by 2025
Global Catheter market = $55bn in 2023
Antibacterial market = $44.5bn 2024
Personal Protective Equipment market = $79.53 billion
Right there thats a maximum of $243bn in just 4 markets that Sintx can play in with antibacterial market being more murky as to if Si3N4 would be used in soaps and such. Thus Sintx need only achieve 1% market penetration to get to $2.4bn and .5% penetration to get to $1.2bn. As Sintx Silicon Nitride is destined to replace titanium and other biomaterials, i'd say its penetration of the ortho market alone would be way more than 1%. Given how effective Si3N4 is against different pathogens it should penetrate into the the catheter market far greater than 1% as well. So yes Sintx IP could easily justify being worth more than $1 billion specifically in the ortho device, catheter, & PPE markets. All the while Sintx current market valuation is ~$4.3m right now (best estimate based on 750k OS).
Orthopedics market set to reach $64bn by 2025 as acquisitions surge, says GlobalData
https://orthospinenews.com/2021/01/22/orthopedics-market-set-to-reach-64bn-by-2025-as-acquisitions-surge-says-globaldata/
The global catheter market size was estimated at USD 54.68 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.57% from 2024 to 2030.
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
Global antibacterial products market size is expected to reach $56.62 Bn by 2028 at a rate of 6.2%
https://www.thebusinessresearchcompany.com/report/antibacterial-products-global-market-report
The global personal protective equipment market size was over USD 79.53 billion in 2023 and is anticipated to grow at a CAGR of 7.2%
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
boston745
2 days ago
Speaking of accumulated deficit. That alone represents significant value for an acquiring company, specifically Zimmer Biomet which would have the best idea of Sintx business, material, etc.. As Sintx has no debt, only assets (offset by small amount of operating liabilities) and this large deficit, an acquiring company would get this large $270m tax offset assuming Sintx can profit as much as its deficit. I of course believe Sintx can for any acquiring company but particular its strategic partners like Zimmer Biomet because its addressable markets are worth upper tens of billions to over $100 billion.
No matter which way you look at it, Sintx is so undervalued that it represents significant value for value investors. Caution is of course needed because of the short and distort campaign being waged against it. One need only look at how posters on this forum, outside myself, focus and overly emphasize the negative aspects of the company. They overplay the negative and downplay all the positives if not ignore them altogether, in their posts. All of which is examples of distorting and bashing oriented posting.
1. Consistent Negativity: One of the key indicators of a stock basher is their consistent negativity towards a specific stock or company. They tend to focus solely on the negative aspects, exaggerating any potential issues or challenges while ignoring positive developments.
https://fastercapital.com/content/Market-Hype--Unmasking-Stock-Bashers--Attempts-to-Manipulate-Buzz.html
========================================
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years. A conspiracy of shorting and distorting.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174597546
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174599544
I go into some of the evidence of this in the February 2023 offering where they drove the price up & naked shorted it down. Ansons family of funds participated in every offering in 2023 up to the recent RS. Anson and the other funds its associated with are known for their short and distort actvity and are under investigation by the DOJ. SEC slapped it with a ticket fine basically that will in no way discourage its shorting and distorting methods.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174602472
========================================
The Value being created at Sintx can be seen in the following posts and links:
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
List of Markets Sintx can participate in and products in development:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174489883
========================================
Sintx valuation should be greater than $230m based on comparable company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174491281
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
boston745
2 days ago
Mantia says investors can also evaluate shareholder value through softer measures such as innovation and competitive dynamics, "which are harder to measure but can be just as important."
Sintx has taken shareholder investment and is creating products. Assuming those products create more value in the end than the cost to produce them, 270m, then shareholder value is created. Ive said many times that Sintx product portfolio is worth more than 230m that Zimmer paid to acquire Implex; Implex being an ortho materials company comparable to Sintx but with an inferior material and market reach. I even asked Joev2 if he thought that Sintx IP could be justifiably worth more than $1 billion for which he will not comment. Thats where management has created shareholder value. That intrinsic value not reflected by the markets representing value investment opportunity on the market side. However due to a short and distort campaign, investors need to participate in shareholder rights offerings to protect their investment until the day Sintx's IP value is finally unlocked.
For example, a technology company with a strong patent portfolio may be seen as more valuable due to its ability to prevent competitors from copying its technology. Similarly, patents can generate licensing revenue, bolstering a company's financial position. Understanding the strategic value of patents and leveraging them efficiently can positively impact a company's valuation, making it an important aspect to consider in the evaluation of a business.
Currently Sonny is ramping up his companies patent portfolio. The number of patent applications jumped from 50s to 140s in the span of a year. This is where Sintx shareholder value is. At some point, it seems coming soon, Sintx will need to start capitalizing on some of these patents. Most of the patents are likely procedural or repetitive covering different markets. Still, there will be core set that represent most of the companies value. This value is not reflected by the companies balance sheet outside of its accumulated deficit.
You contend that shareholder value is simply based on equity and stockprice based on the quote you posted. Sintx IP value is not reflected on Sintx's balance sheet as an asset and thus you cannot see value being created on paper. Stockholders accumulated deficit does give us an idea of the value but only if that value is worth more than the companies deficit. Again i show rationale for Sintx IP being worth more, significantly more, than its accumulated deficit.
Sintx stockprice does not even reflect Sintx book value representing a value investment opportunity without even factoring in IP. This is, in part, a problem created by a conspiracy of hedge funds shorting and distorting Sintx for 9 years.
What will end up happening, is all that value being created on the IP side, when finally unlocked, will come flooding into the market and SINT will skyrocket. What should have happened over the years is that value should have gradually increased SINT price as more value was created in the companies IP. Shareholder value is locked up for some reason. Its there but not obvious unless you do your research.
I go into evidence of a short and distort scheme going on for 9 years below. In addition to that i show that Sintx IP is worth at minimum $230m, representing a significant value opportunity over Sintx current valuation. In reality Sintx material portfolio is worth significantly more than that because Sintx main material represents a disruptive product that could one day dominate the ortho markets as well as penetrate several other markets!
========================================
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years. A conspiracy of shorting and distorting.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174597546
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174599544
I go into some of the evidence of this in the February 2023 offering where they drove the price up & naked shorted it down. Ansons family of funds participated in every offering in 2023 up to the recent RS. Anson and the other funds its associated with are known for their short and distort actvity and are under investigation by the DOJ. SEC slapped it with a ticket fine basically that will in no way discourage its shorting and distorting methods.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174602472
========================================
The Value being created at Sintx can be seen in the following posts and links:
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
List of Markets Sintx can participate in and products in development:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174489883
========================================
Sintx valuation should be greater than $230m based on comparable company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174491281
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
joev2
2 days ago
You tend to obfuscate the bottomline often my friend, rather than deal with the topic head on. The point I was simply making was that like-minded individuals/ businesses often hang with the same. The "hearsay" was based on the comment from Reddit; a comment that I did not check as to its veracity (but do tend to believe, nevertheless).
Yes madg, we can trust them, can't we? Anyway, good to hear from you as always. Looks to me like the same ol' same ol' from our friends at Sint, only they're limited now from doing their never-ending offerings and reverse splits. I for one, would not advertise that I'm working with Ascendiant to expand my business. IF anything, I would think that would scare any legit firm or knowledgeable investor from looking any further, bwdik? But when you're desperate, you're desperate.....
joev2
2 days ago
Some thoughts on Ascendiant Capital and yes, it's hearsay from my perspective. Still, it should cause one to pause.
Ascendiant and Wedbush both have a history of naked shorting, lock/cross trading, failure to report shorts, and fines by FINRA, SEC, NYSE, and NASDAQ. They're off-Wall Street broker-dealers on the fringes of the securities world. Ascendiant provides "research" for obscure biotech investments that they also promote stock offerings for, so they're essentially a high-class boiler room. Ascendiant also has a fund that is losing money, and they are late reporting last year's results. It seems possible (but not proven) that Ascendiant's investment fund is short on GameStop and trying to stop the bleeding.
https://www.reddit.com/r/DDintoGME/comments/muux3w/ascendiant_and_wedbush_who_are_they_and_why_are/
And....
https://securitiesarbitrations.com/ascendiant-capital-markets/
boston745
3 days ago
Point of fact since 2019 when they first engaged Ascendiant Capital, there has been alot of value creation...just not in the dental markets that we are aware of.
Plethora of antipathogenic product candidate.
Armor products/division was added
TAT was added with additional ceramic compositions
Defense was added
Si3n4 imbued PEEK products
Aerospace products
Cancer treatment product(s)
Further development of 3D printing applications.
This isnt even comprehensive. In regards to cancer treatment, it appears the product is optical sensor related. I say that because this part was included in the PR:
The company is also one of the few manufacturers of optical ceramic materials for sensor applications.
I go into a possible cancer treatment product here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174502508&txt2find=sensor
More recently, the Company’s femoral head technology has attracted renewed interest from several global partners.
The previous strategic partner on this was Zimmer Biomet so are they one of the several global partners?
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
List of Markets Sintx can participate in and products in development:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174489883
========================================
Sintx valuation should be greater than $230m based on comparable company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174491281
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
boston745
3 days ago
With technologies targeted at the medical, defense, and renewable energy markets, year-over-year growth in revenues, and other commercial opportunities in the pipeline, SINTX will require additional investment and resources. As such, we want to examine all strategic opportunities targeted at maximizing shareholder value,” said Sonny Bal, Chief Executive Officer and Chairman of SINTX. “We believe that potential partners will find significant value in SINTX’s businesses and capabilities.”
Looks like they are looking for a company/fund to take a stake in Sintx. They are in need of commercialization partners as well.
https://ir.sintx.com/news-events/press-releases/detail/233/sintx-technologies-to-explore-strategic-opportunities
Last time Mic, they were looking at just the dental markets. What they are looking for now seems to be much larger. This was last time.
“Ascendiant Capital”), as investment bank and advisor, to identify strategic opportunities in the dental space.
“While we have been working closely with dental implant companies in specific development projects, Ascendiant Capital will play a critical role in disseminating our R&D advancements to a wider audience of partners, and helping commercialize the technology,” stated Dr. Sonny Bal, President and CEO of SINTX. “We are excited to represent SINTX Technologies, having deep experience and knowledge of dental companies worldwide,” said Dr. Christopher Gayde, a former practicing dentist and Managing Director of Ascendiant Capital’s Dental Investment Banking Group.
https://ir.sintx.com/news-events/press-releases/detail/139/sintx-technologies-announces-engagement-of-ascendiant
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
List of Markets Sintx can participate in and products in development:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174489883
========================================
Sintx valuation should be greater than $230m based on comparable company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174491281
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
boston745
4 days ago
Notice how in my post i addressed your points but in your reply you failed to which implies you agree with the points. While you did clarify something, you've manage to change topic away from the points i laid out.
I do not simply defend Sintx, i highlight cons or scams. I do it here. I do it over on Teslas board. I did it on Pernix board as well. Tesla is one of the biggest, if not the biggest, fake it until you make it scam in the world. Pernix, when i was posting on its boards, was being pumped by hired posters. They pumped how it was an acquisition target because its CEO has sold some of his previous companies. The posters pumped this all the while Pernix was in really bad financial shape; loads of debt and drugs that were becoming outdated replaced by cheaper generics. After looking over its financials and filings I declared it would go bankrupt and debated those fund's pumpers for a time. Funds were trying to scam people into buying into their fabrication yet two years later Pernix went bankrupt exactly as i said it would. Tesla is no different but on a much larger scale. I declared Tesla to be a fake it until it makes it scam and shortly after, news of DOJ investigation into it was announced. Not in regards to Tesla cars, that part isnt the scam, but the gross overstatement of how good Teslas self driving tech was and how soon it could deliver robotaxis where owners could make money off their Teslas. Thats still years away if ever. I do not believe Tesla will ever be able to deliver a level 5 network because EM radiation will continue to cause its cars to go out of control and kill people. Something i began to declare in 2021 to much criticism and ridicule. Over time, however, evidence confirming my original hypothesis has only grown...just like the evidence ive collected showing Sintx has very valuable IP, large strategic partners, IP worth a sizable amount, and tech that is game changing. Obviously just recently, i finally showed proof that SINT has been undervalued and manipulated due to a conspiracy of hedge funds that have been shorting and distorting it. Something i have felt was true for years but lacked the evidence. Now its as plain as day!
Like those cons games by funds and even management at Tesla, i have declared that there has been a con here. Not a con to get people to buy as in those two, but the opposite. A con to get people to sell, to run away from SINT and never come back; i however encourage people to keep watching. As ive said, Wallstreet can make a piece of shit company look like a golden goose and a golden goose look like shit. Thats whats happened here. WS has disguised SINT/Sintx as a POS when its in fact a golden goose.
My post showing that Tesla = fake it until you make it scam
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174085276
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
List of Markets Sintx can participate in and products in development:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174489883
========================================
Sintx valuation should be greater than $230m based on comparable company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174491281
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
joev2
4 days ago
To clarify in my last message, I'm talking specifically about defenders of such stocks like Sint; whereas 'winners' (meaning clearly above board companies) do not have people overemphasizing the 'playing' of the stock price.... These companies just do 'normal' business with various credible institutions and lenders moving them along. There's no constant drama (unlike poorly run penny plays) thrown into the mix all the time as to why the continual under performance. For the most part, if problems do arise, a company will make whatever change is necessary in order to keep the investment community interested and the company a worthwhile investment. Defenders of penny play fails, blame outside forces instead of where it belongs i.e. management, bod, etc. I see it all the time.
boston745
4 days ago
is it of your opinion that EVERY institution, EVERY insider and EVERY credible lender feels the same viz that they
show blinders to the value theyve created?
But Joe, management has created significant value, that is undeniable. While you can claim, with some evidence supporting that claim, that management is too incompetent to utilize the value created. As i said in my previous post, management or really Sonny is tied to a major player in the ortho industry. That player is not as incompetent as you believe management to be. Mr Bray is tied to a major player in the aerospace industry. Mr Palomo tied to a major player in the PPE (Antipathogenic) industry. While Joseph Palomo & Donald Bray are no longer with Sintx as employees, serving as consultants, they seemingly got Sintx ready to supply the companies from which they came. Thats a fact for Morgan Ceramics, while appearing to be true for NP Aerospace (specific division Bray oversaw within Morgan) & Cardinal Health for which Palomo was from. Since most of these things are established fact, I agree its odd that tutes & insiders have not begun taking positions yet. Insiders, including the current CEO, were buying before Sintx IPO'd. It seems something about going public caused them to stop. Thats when Anson's family of funds jumped in and began shorting and distorting. Thats also a fact, a conspiracy of funds manipulating the stockprice as ive been saying all these years. Again undeniable as thats precisely how they operate with evidence here of precisely that.
Thus i do not give weight to the lack of insider/tute buying that you do. I instead see that variable as being used as a distraction, as part of crafting an illusion, driving a false narrative. So yes, the lack of buying means something, just not what you are suggesting. That said, several major tutes are in fact keeping an eye on Sintx through small holdings (Blackrocks and Wells Fargos types); something thats been true for years. Thus negating your "winners" aren't noticing point. This suggests they are waiting for something. What that something could be, is still unclear.
joev2
4 days ago
Speaking of variables, is it of your opinion that EVERY institution, EVERY insider and EVERY credible lender feels the same viz that they
show blinders to the value theyve created?
Do you feel that ALL of the above mentioned fit this statement directed towards me as well?
If you are going to properly analyze things here you have to give these variables their proper weight. You have a bias toward management Point is (again) no one invests, no one lends and no one ever has, other than Maxim types and Anson types. That's problematic! And what's also problematic is that it appears EVERY penny stock that behaves similarly to Sint, gets the same treatment viz conspiracy, collusion, illegal shorting etc instead of on the company itself (most notably management and to some extent, product as well). Not to say there isn't any (games of that sort) in play here, only that it's seemingly always overemphasized with the 'losers', yet the 'winners' never seem to take notice.
boston745
5 days ago
I have trouble believing they do not "trust" management simply because its managements connections that play a significant role in why Sintx could be worth as much as it is. I think theres something else that holds them back for now...
I find it interesting that you seem to exaggerate the role management plays in the state of its stock while downplaying the positives they bring to the company along with the value theyve created. You do this while also downplaying the game the shorters & distorters play. Im not talking the leech shorters that join in for the ride, i mean the main players manipulating the stock downwards. I think Anson's group of hfunds is here serving a purpose, the question is who's purpose? If they drop the stock enough they'll lower the strike price of my warrants so you'd think i'd want them to reduce my costs. Yet i fight against my own self interest because Sintx needs to be properly valued like yesterday and the tech development/commercialization going asap! The tech is too important for the future!
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
List of Markets Sintx can participate in and products in development:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174489883
========================================
Sintx valuation should be greater than $230m based on comparable company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174491281
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
boston745
5 days ago
TA, you are going to have to do better than using truth to tell lies; precisely what people engaged in disinformation/short & distort campaigns do. You claim that Sintx is a share dilution scam because Sintx has to raise funds to continue operations. That is not a share dilution scam per your reference.
What has happened here is due to the short and distort campaign taking advantage of the fact that Sintx needs to raise money to fund R&D; which leads to it overly diluting with each offering and then reverse spliting to stay listed. Is my description of what has occurred the last 9 years accurate or yours? First off, for Sintx to be a share dilution scam it would need to raise funds just because. There is little detail on this sort of scam so im going to go out on a limb and assume there is not much of real value being created on the company side that is involved in these sorts of scam.
Why Sintx/SINT cannot be a share diluting scam!
During Sonny's tenure as CEO, Sintx IP has grown significantly, something you cannot honestly deny. Meaning Sonny has overseen, partially created as well as hes a contributing scientist, a massive expansion of Sintx product candidates branching off into many new possible markets. From Cancer to Anti-pathogenic to Aerospace/Defense to many other possible uses just within the ortho/medical sector. So no Sintx cannot be a share dilution scam for the simple reason so much value has been created but for reasons i already shown, that value is not reflected by the markets because Sintx has been under a short and distort campaign for 9 years as i show in links below. Sintx market value should exceed $230m. So why is it currently worth $3.5m? I dont just claim this, anyone can verify that a comparable materials company was acquired for 230m by Zimmer back in 2003. As Sintx material is superior to that of Implex Hydrocel, has more strategic partnerships in place with at least 2 large companies, & can be used in so many additional markets in addition to the ortho market, its worth more than $230m. In fact Joev2 still hasnt answered my question if Sintx IP is worth more than 1 billion based on its addressable markets and known/suspected strategic partners.
In conclusion, Sintx/Amedica, cannot be share dilution scam for the simple reason that too much value been created with the funds raised. Instead evidence suggests SINT only APPEARS to be a share dilution scam because of the conspiracy of hedge funds engaged in a short & distort campaign against it for 9 years.
https://stocktwits.com/TAman87/message/576726282
========================================
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years. A conspiracy of shorting and distorting.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174597546
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174599544
I go into some of the evidence of this in the February 2023 offering where they drove the price up & naked shorted it down. Ansons family of funds participated in every offering in 2023 up to the recent RS. Anson and the other funds its associated with are known for their short and distort actvity and are under investigation by the DOJ. SEC slapped it with a ticket fine basically that will in no way discourage its shorting and distorting methods.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174602472
========================================
The Value being created at Sintx can be seen in the following posts and links:
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
List of Markets Sintx can participate in and products in development:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174489883
========================================
Sintx valuation should be greater than $230m based on comparable company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174491281
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
boston745
6 days ago
Pitk account seems to be part of the short n distort campaign. Either that or they want to be seen as part of it. They like to use me as a scapegoat for their actions.
Deckmaxx = Boston, be wäre the main pumper is on board
Deckmaxx is most likely connected to the short and distort campaign in that there is usually an account that acts bullish. If Deckmaxx was me itd be obvious especially with the new info I stumpled upon.
https://stocktwits.com/PitK17/message/576716590
Taman87 has been a part of this short and distort campaign since Anson family of funds bought Fall 2015 bashing Sintx the entire time.
https://stocktwits.com/TAman87/message/576698166
========================================
This posts shows shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years. A conspiracy of shorting and distorting.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174597546
This post shows how this group of funds work together to short offerings and buy them so, as the above shows, to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174599544
Meanwhile, below is what this short and distort group doesnt want you to see while they keep you distracted with low prices, excessive offerings, & reverse splits all which they help create via their Short and Distort campaign.
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
List of Markets Sintx can participate in and products in development:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174489883
========================================
Sintx valuation should be greater than $230m based on comparable company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174491281
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
boston745
6 days ago
There is a specific SEC rule against short selling stock just before a public offering and then buying back the stock in the offering
According to the SEC rule referenced, Affiliate businesses (Fund B, C, D, etc) can short the company while Fund A buys the offering. This could be another reason why Anson is but one of many funds in this family of funds.
(3) Investment companies. Paragraph (a) of this section shall not prohibit an investment company (as defined by Section 3 of the Investment Company Act) that is registered under Section 8 of the Investment Company Act, or a series of such company (investment company) from purchasing an offered security where any of the following sold the offered security short during the Rule 105 restricted period:
(i) An affiliated investment company, or any series of such a company; or
https://web.archive.org/web/20200809144313/https://www.law.cornell.edu/cfr/text/17/242.105
Still, my post proves beyond a shadow of all doubt that there has been a conspiracy of funds working to short SINT despite claims no such things were going on by the very accounts which distort facts about Sintx on ST/Ihub.
This posts shows shows that there is a family of funds associated Anson Group and how those funds took turns participating in Sintx stock offerings over the years.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174597546
This post shows how this group of funds work together to short offerings and buy them so, as the above shows, to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174599544
One of the most obvious examples of them trading on material non-public information was the run up of SINT to $2,418 ($12.09 pre-RS) on Feb 3rd 2023. This group seemingly ran the price up ahead of this offering price news to the aforementioned $2,418 and naked shorted just 3 trading days before the offering where the stockprice dropped from close of $1,863 ($9.31) Feb 3rd and closed at 666.52 (3.33) on Feb 8th. Two of Anson family of funds bought this offering. Lind Global and Intercoastal Capital. If either of these two funds naked shorted this offering this would be a violation but its likely that the other funds in this family did the naked shorting. Another interesting thing to note is how each fund took turns buying offerings thus spreading out profits and tax write offs between funds.
This article indicates how Anson and this group of funds utilize european markets for their naked shorting. Do they even need to do this via European markets when they have off-shore funds in the Caribbean?
How Anson Funds Skirts Naked Shorting Rules with Help from Big Banks, Brokers and European Regulators.
https://marketfrauds.to/moez-kassam-anson-funds-the-big-secret/
I suspect this article is truth mixed with lies as very little is sourced to anything verifiable. Not likely entirely how they operate (missing sister funds for instance) and is meant as misdirection. Still it'll contain some nuggets of truth within.
========================================
Not only have i shown there has in fact been a conspiracy of funds shorting SINT since 2015 (they've also have several accounts distorting facts about Sintx on ST/IHUB), ive also shown that Zimmer Biomet/subsidiary is/was Sintx strategic partner pertaining to the testing and development of hip implant utilizing Sintx femoral head. This after being told several times that Zimmer Biomet supplying its liners for this testing means nothing.
Proof Zimmer Biomet is one of Sintx strategic partners:
Sintx 2016 10k
Together with a strategic partner, we have initiated biomechanical testing of our solid silicon nitride femoral heads. The results of this test will be released in 2017
This quote indicates the results of testing of their femoral head with a strategic partner will be released in 2017.
Those results were released testing Sintx Femoral head against Biomet's E1 liners. Thus Zimmer Biomet, or any of its subsidiaries, is Sintx strategic partner in this testing.
Amedica and Zimmer-Biomet (Tokyo Office) provided the femoral heads and acetabular liners; however, neither company actively sponsored the research
These are risk-averse companies that look to smaller companies like us to develop an idea, uh, and, uh, de-risk it, so to speak, and then buy that technology.
Quote Sources:
https://web.archive.org/web/20240408163612/https://spineblogger.blogspot.com/2011/05/whos-next.html?m=1
2016 10-k pg 13: https://www.sec.gov/Archives/edgar/data/1269026/000149315217010752/form10-k.htm
2017 results: https://ir.sintx.com/news-events/press-releases/detail/95/amedica-announces-results-of-independent-femoral-head-wear
https://web.archive.org/web/20240408152758/https://sintx.com/wp-content/uploads/2021/03/Investor-Call-Transcript-033021.pdf
boston745
7 days ago
This is essentially how the Anson family of funds (is Anson at the top of this family?) work SINT and its offerings.
Here is a trade that is almost guaranteed to make money, though it is also double super illegal.
These companies -- there were 13 of them, all pretty small -- raised money through what the SEC calls "confidentially marketed public offerings." A company would engage an investment bank, which would call up potential investors and ask if they wanted to buy shares in the company. The bank would do this before the company publicly announced the offering, and would "wall-cross" the potential investors, making them agree to keep the information about the offering secret until it was announced publicly.
So here's a predictable stock-market pattern and an easy way to exploit it: If a company calls you up to ask you to invest in its upcoming public offering, you should (1) say yes, (2) sell the company's stock short before the public announcement, and then (3) buy the stock back in the public offering, generally at a 10+ percent discount, a few days later.
This is of course not legal advice! It is a great trade, but it is also double super illegal, insofar as:
There is a specific SEC rule against short selling stock just before a public offering and then buying back the stock in the offering, 5 and
There is a general, and much more important, rule against trading on purloined material nonpublic information, and this is that.
trading in breach of that agreement, you are clearly violating not just the contract, but also insider trading laws, which make it illegal to trade "in breach of a fiduciary duty or other relationship of trust and confidence, while in possession of material, nonpublic information about the security."
But, you know, who will check?
Some of the funds would get wall-crossed, and then they'd tip each other and trade in the other funds to try to obscure what was going on:
When they were successful in obtaining such information, Fishoff shorted the issuer’s stock in advance of the offerings, directed trading by Chernin and Costantin in those instances when he did not place the trades on his own, and tipped Petrello, who then also shorted the stock through Brielle and Oceanview.
In many instances, the Fishoff-controlled entities for which Chernin and Costantin were fronting also participated in the offering, with the stock going to Featherwood’s account and often being used to cover the short sales.
This right here is most likely how this family of funds worked. 1+ of them would get information of a forthcoming offering which it would later participate in, and tip the others off so they can pre-short. Not sure why the author says pre-short, wouldnt this be naked shorting? They then used the shares from the offering that Fund #1 received to cover those naked short positions?
By cheating on their wall-cross agreements and shorting the stock, these guys had the effect of driving down the stock price, which probably reduced the price in the offering. These companies probably got less money for their stock because their nonpublic information was (allegedly) used against them.
Joe, this next part does have merit here and could support what you've claimed about management and the board.
Though you could have a more cynical view of this sort of thing. A company needs to sell stock, but worries that announcing a public offering will drive down its stock price and not produce any takers. So it calls some investors up privately and tells them it's doing a deal. Those investors agree to invest in the deal, but before the deal is announced they lay off their risk by shorting the company's stock. Then the deal is announced and the investors buy shares from the company to (illegally) cover their shorts. The investors get their 10 percent, or whatever, discount to the market price as a commission; their real function is not to invest in the deal but to intermediate between the company (which can't sell stock without a publicly disclosed offering) and the unsuspecting public (which buys from the "investors" before the public disclosure). The wall-cross agreement creates deniability for the company. No one's stealing from the company; they're helping the company get a deal done that would otherwise be much harder to achieve. The victims are the public who buy from the insider traders at the inflated, pre-announcement price.
There is definitely evidence supporting this, especially between 2022 RS & 2024 RS. For instance, Lind Group participated in the offering at .25 and per our discussions Joe, funds naked shorted from as high as .50s before Lind used their shares to cover those shorts at .15. Thus this group of funds "laid off their risk", making millions in a few days, and did in fact work as an intermediary between the company and the public as they dumped shares. Lind Group sold off its shares in a matter of days. This group of investors gets a hell of alot more than 10% off these offerings. After factoring in the 200:1 split theyve been shorting since 100 with a hell of a pump and dump between .04 to .22 pre-split (8-44 post split).
https://web.archive.org/web/20190331202955/https://www.bloomberg.com/opinion/articles/2015-06-03/insider-traders-made-some-easy-money-on-stock-offerings
Something Xena posted years ago here and it seems to correlate with all this, especially post split as theyve been walking the price down.
The 10000 can be wash traded back and forth freely between colluding computers. Tons of money is made so they can now walk the stock down even lower because risk has been reduced.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=139777542
That seems to correlate with this wash trading where funds can increase (decrease) the price with this action.
How To Run a Pyramid Scheme — But On The Stock Market
https://www.reddit.com/r/wallstreetbets/
joev2
7 days ago
In my opinion, Anson and his ilk are nothing but gamers AND Bal (with the help of management and the bod of do-nothings) made it exceptionally easy for them. I've said it many times. When you don't come through in your news releases; never address your shareholders (let alone even acknowledge they exist); have ONLY CLOSED conference calls or skip them all together during earning season, you give NO incentive whatsoever to invest. However, you completely open the doors for the shorters (smart people) and the gamers (also smart people) to have a field day....and a field day, they did!
I'll also add, the numerous offerings and reverse splits ALL BEING AFTER the stock was ALREADY down 99%, didn't help. I personally can only come to one of two conclusions about management: a) corrupt; b) clueless.
Boston, thank you for being so detailed oriented. It's interesting how the Ansons of the world work.
boston745
7 days ago
Things just go SOOOO much more interesting with this revelation. It shows there has in fact been a conspiracy of funds, shorting and distorting Sint & Sintx since 2015. My next post will give some insight into how this family of funds might operate. This includes shorting before offerings exactly as ive said was occurring but it looks like the other funds do the shorting and then cover with the shares the fund that bought the offering received. Also seems to include wash trading back n forth just like Xenalives has posted in the past.
Plaintiff further asserts that many of the potential investors that it contacted on behalf of Defendant operate as a family of hedge funds, all managed by the same investment advisor.
List of potential investors the Plaintiff was referencing. All the funds that seem to be connected are in red.
List named the following:
• Anson Funds Management LP and its affiliates
• Ayrton Capital, Altos Opportunity Fund and their
affiliates
• Crede Capital Group, Acquitas Capital and its affiliates
• CVI Investment, Heights Management, SIG and their
affiliates
• Connective Capital and its affiliates
• Empery Asset Management and its affiliates
• Intracoastal Capital LP and its affiliates
• Hudson Bay Capital Management and its affiliates
• Ionic Venture LLC and its affiliates
• Lind Partners and its affiliates
• Li Capital Global Opportunities Master Fund and their
affiliates
• Sabby Management LLC and its affiliates
Source of this list:
https://images.law.com/contrib/content/uploads/documents/404/140289/51-2023-08-31-043-Order-Denying-SJMotion.pdf
List of Funds that have had stakes in AMDA/SINT at one time or another. You'll notice that 3 of the family of funds bought recent offerings of Sintx.
4/01/2024 L1 Capital Global Opportunities Master Fund, Ltd.
https://www.sec.gov/Archives/edgar/data/1269026/000107997324000472/0001079973-24-000472-index.htm
2024-05-14 13F Anson Funds Management LP 959,297 47
https://fintel.io/so/us/sint
2/07/24 Lind Global Fund II LP
https://www.sec.gov/Archives/edgar/data/1269026/000092963824000396/0000929638-24-000396-index.htm
2/16/2023 INTRACOASTAL CAPITAL, LLC
https://www.sec.gov/Archives/edgar/data/1269026/000121390023012455/0001213900-23-012455-index.htm
2/14/2023 Lind Global Fund II LP
https://www.sec.gov/Archives/edgar/data/1269026/000092963823000614/0000929638-23-000614-index.htm
05/18/2018 CVI Investments, Inc.
https://www.sec.gov/Archives/edgar/data/1269026/000110465918034362/0001104659-18-034362-index.htm
01/19/2017 SABBY MANAGEMENT, LLC
https://www.sec.gov/Archives/edgar/data/1269026/000153561017000068/0001535610-17-000068-index.htm
07/14/2016 ALPHA CAPITAL ANSTALT
https://www.sec.gov/Archives/edgar/data/1269026/000121390016014963/0001213900-16-014963-index.htm
9/14/2015 Frigate Ventures LP = Anson Group
This Schedule 13G (this “Schedule 13G”) is being filed on behalf of Frigate Ventures LP (d/b/a Anson Group), a Texas limited partnership (“Frigate”), Admiralty Advisors LLC, a Texas limited liability company (“Admiralty”), Mr. Bruce R. Winson, the principal of Frigate and Admiralty, M5V Advisors Inc. (d/b/a Anson Group Canada), an Ontario, Canada corporation (“M5V”), Mr. Adam Spears, a director of M5V, and Mr. Moez Kassam, a director of M5V, relating to Common Stock, $.01 par value (the “Common Stock”), of Amedica Corporation, a Delaware corporation (the “Issuer”).
https://www.sec.gov/Archives/edgar/data/1269026/000119312515319457/0001193125-15-319457-index.htm
Hudson Bay Capital Management LP 2,789,867 2.16 870,438 Sep 30, 2015
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=118775462
XenaLives connecting CVI to ALPHA CAPITAL ANSTALT
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143618825
boston745
1 week ago
For years ive been speculating that there was an activist investor behind the scenes with Sintx and Anson Fund could be just that for which Sonny has been trying to protect Sintx from. Its a fund that's participated in offerings with a investment manager thats been tied to Sintx offerings since 2015; Mr. Moez Kassam, co-founder of Anson but investing via M5V in the 2015 offering (linked below). If Anson and Kassam were behind any campaigns to short and distort Sintx, then all those bashing Sintx on stock forums, are helping (knowingly or not) such a short and distort scheme.
There have been claims, particularly on ST, Sonny was in bed with Kassam/Anson. Maybe they meant Sunny Puri one of Ansons analysts? Naturally there has been no disclosed evidence to substantiate such statements of Kassam/Anson & Sintx CEO, just baseless claims. Here is an article on an alleged campaign orchestrated by Anson Fund. Its interesting that those bashing Sintx invoke Anson Fund to in such a manner to scare people away from SINT.
Catalyst Capital Group Inc. has launched a lawsuit against Anson Group Canada, a privately held asset manager with operations in Canada and Texas, and Toronto-based private equity firm West Face Capital Inc., accusing them of participating in a “manipulative ‘short and distort’ campaign.”
The alleged target was publicly traded Catalyst subsidiary Callidus Capital Corp., claims the lawsuit, which dubs the Anson, West Face and several associated and unrelated individuals as “Wolfpack Conspirators.”
The lawsuit, filed Tuesday in Ontario’s Superior Court of Justice, claims the group targeted Callidus with a short-selling strategy that involved coordinating with and providing financial support to a group of borrowers who had defaulted on loans to Callidus, and were fighting to prevent Callidus from collecting.
It also alleges use and attempted use of the news media to further their short-selling campaign, improper use of a new regulatory whistle-blowing program, and coordinated buying and selling of shares.
Among others, the lawsuit also names Anson principals Moez Kassam and Adam Spears and analyst Sunny Puri,
Recently Anson Fund got a tiny slap on the wrist from the SEC for its short selling schemes which seems to include some blue-chip names. Course if funds like Anson can pay a couple bucks (millions) in fines, while making hundreds (millions), this will not discourage the behavior. Im curious if the small fine was because the SEC couldnt find anything substantial or because its protecting some blue-chip names? A minor infraction is a way to save face and protect any blue-chips connected to Anson's schemes.
The minor nature of the infraction and the small size of the settlement was far from the grand hype that surrounded the investigation, which was said to involve dozens of short sellers, and numerous companies, including some blue-chip names. One fund manager called the SEC settlement with Anson “a consolation prize for some ticky tack bullshit.”
I previously said that i thought that Sonny did shareholder rights offerings in part to block/defend against attempts by hidden activist investors to go after board seats which apparently Anson Fund is stepping up action to accomplish. Shareholder rights offerings have come shortly before two annual meetings to vote on board seats. Its possible that Anson is one such fund as it plans, beginning in 2023 (likely has been going on since before then) to work behind the scenes of target companies as an activist investor.
Anson Funds hires Legion Partners' Gupta to build out activism strategy
"Anson has a long history of driving differentiated and uncorrelated returns - activism is a natural extension for us," Anson's founder and chief investment officer Moez Kassam told Reuters.
The firm plans to work behind the scenes with target companies but is ready to launch public campaigns, including pushing for board seats for Gupta and others, the company said.
Mr. Adam Spears, a director of M5V, and Mr. Moez Kassam, a director of M5V
Quote Sources:
https://financialpost.com/news/fp-street/catalyst-capital-files-450-million-lawsuit-accusing-anson-funds-west-face-of-short-selling-conspiracy
https://www.reuters.com/article/idUSL2N3B82SO/
https://www.institutionalinvestor.com/article/2dcxth6clfikh5eel0zcw/corner-office/anson-funds-settles-with-sec-in-long-running-short-seller-probe
https://www.sec.gov/Archives/edgar/data/1269026/000119312515319457/d18496dsc13g.htm
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
List of Markets Sintx can participate in and products in development:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174489883
========================================
Sintx valuation should be greater than $230m based on comparable company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174491281
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
boston745
1 week ago
Air Canada plane makes emergency landing at Sacramento International Airport after engine failure
An engine failure aboard an Air Canada Express commuter flight from Sacramento International Airport caused the pilots Tuesday to turn around and return to the capital city’s airport. The plane — Air Canada Express flight 7121 — took off bound for Vancouver, British Columbia, about 40 minutes late at 9:52 a.m., according to FlightAware, an online plane tracking system. The plane operated by Jazz Aviation is a CRJ-900LR, a regional jet that seats 76 passengers, and was built by Bombardier in 2005. However, the small jet’s left engine, a General Electric model CF34-8C5, failed shortly after takeoff and a crew of four people aboard was diverted. The jet safely landed about 10:35 a.m., according to archived audio dispatch calls reviewed by The Sacramento Bee.
https://www.sacbee.com/news/local/article289182999.html
So many airplane engine failures...
I continue to warn about engine failures due to EM radiation and that Sintx may have a solution that could reduce the frequency of failures as the earths magnetic field continues to weaken. As always Sonny & Hanson, be careful flying. Make sure you or your pilots are adequately trained to deal with engine failures, hydraulic failures, and loss of wheels/tires.
SINTX has a long history of developing composites and coatings for extreme environments. Our 30 years of experience has allowed us to gain expertise with both C and SiC fibers, debond coatings including carbon and SiC, dozens of different options for the composition and the production process for the ceramic matrix, and a wide array of final barrier coatings.
Our Ceramic Matrix Composite (CMC) experience initially was focused on Carbon/SiC and SiC/SiC based formulations, but this material family has a wide array of options which tailor the properties such as density, strength, oxidation resistance, and wear resistance.
https://www.techassess.com/technologies/advanced
Heres a good CMC application for EM radiation absorption. Something i posted 4 years ago in hopes it might help mitigate EM radiation that causes things like airplane engine failures leading to so many plane crashes.
Electromagnetic wave absorption and mechanical properties of silicon carbide fibers reinforced silicon nitride matrix composites
https://www.sciencedirect.com/science/article/abs/pii/S0955221918307568
========================================
Joe, you see all those large names with exploratory positions and you focus solely on Anson which had a tiny position, for Anson, at 1m shares (around 1% of OS pre-RS). Usually if Anson participates in an offering they own 5+%. Several of those funds are tied to Zimmer Biomet. The most prominent is Blackrock to Zimmer and Wells Fargo to Biomet. Blackrock has been in and out over the years.
I wonder what these tutes are waiting for while they continue to watch?
I'd bet that Anson sold its shares during the pump to the 40s (.20s pre RS).
1. Consistent Negativity: One of the key indicators of a stock basher is their consistent negativity towards a specific stock or company. They tend to focus solely on the negative aspects, exaggerating any potential issues or challenges while ignoring positive developments.
https://fastercapital.com/content/Market-Hype--Unmasking-Stock-Bashers--Attempts-to-Manipulate-Buzz.html
boston745
1 week ago
This says otherwise. Some big names keeping small positions in Sintx and have been for years. Only requires 1 share to request info from management. Theyve been keeping an eye out on Sintx for a reason...
2024-05-20 13F Virtu Financial LLC 0 -100.00 0
2024-05-15 13F Bank Of America Corp /de/ 0 -100.00 0
2024-05-15 13F Tower Research Capital LLC (TRC) 9,481 572.89 0
2024-05-15 13F Two Sigma Securities, Llc 84,812 736.08 4 33.33
2024-05-15 13F Morgan Stanley 2,228 -0.09 0
2024-05-15 13F State Street Corp 17,293 0.00 1 -100.00
2024-05-14 13F Anson Funds Management LP 959,297 47
2024-05-13 13F Geode Capital Management, Llc 21,894 -1.61 1 -87.50
2024-05-13 13F Hrt Financial Lp 17,967 0
2024-05-13 13F Fmr Llc 41 0
2024-05-10 13F Vanguard Group Inc 43,409 0.00 2 -87.50
2024-05-10 13F Wells Fargo & Company/mn 42 27.27 0
2024-05-10 13F BlackRock Inc. 0 -100.00 0
2024-05-10 13F Jpmorgan Chase & Co 29 3.57 0
2024-05-10 13F Advisor Group Holdings, Inc. 18 -5.26 0
2024-05-08 13F Heritage Wealth Advisors 524 52,300.00 13
2024-05-07 13F Cornerstone Planning Group LLC 1 0.00 0
2024-05-03 13F Signaturefd, Llc 573 0.00 0
2024-05-02 13F Kestra Private Wealth Services, Llc 10,000 0
2024-05-01 13F Proequities, Inc. 0 0
2024-04-25 13F Allworth Financial LP 1
https://fintel.io/so/us/sint
boston745
1 week ago
Absolutely NO INVESTMENT FIRM, INSIDER or credible lending institution takes Sint for anything other than the joke that it is; hence it is left alone.
Setting aside for a second that this post was meant in an antagonist manner (disinformation technique), as this is your goto statement, im beginning to wonder if this is done on purpose so you can claim it? Not you specifically but accounts like yours that use this statement to try to deflect from the development side of Sintx. You have little else other than the suppressed stockprice with the excessive dilution/reverse splits that comes with it, and lack of any ownership to really point to; exception being pre-IPO. This is only true until its not and theres a lot of reasons for this not to stay this way forever.
You seem to want people to believe that this means Sintx is a joke. However outside of the markets there is nothing to imply Sintx is a joke. Not the research showing that Silicon Nitride is destined for great things in the medical field. Not Zimmer Biomet involvement. Not Morgan Ceramics involvement. Nor any of its other strategic partners. Certainly not the US military which is working with Sintx on developing several products. Working with the US military should be your first clue that Sintx is not a joke as you seem to want people to believe. Before you bring up some rando company that you are aware that folded but worked with the military, make sure it was in a similar financial state. As in little if any real debt and a plethora of product candidates along with major strategic partners.
Having said all that you said SINT is a joke not Sintx.
This contract will address material challenges in propulsion and guidance technology for next generation high-temperature Department of the Air Force systems.
https://ir.sintx.com/news-events/press-releases/detail/231/sintx-technologies-receives-additional-sbir-contract-for-3d
SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET
https://ir.sintx.com/news-events/press-releases/detail/223/sintx-technologies-enters-into-a-second-long-term-supply
SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY
https://ir.sintx.com/news-events/press-releases/detail/220/sintx-subsidiary-technology-assessment-transfer-to
SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS
https://ir.sintx.com/news-events/press-releases/detail/217/sintx-technologies-enters-a-long-term-supply-agreement-for
SINTX TECHNOLOGIES AWARDED PHASE I CONTRACT FROM THE MISSILE DEFENSE AGENCY FOR ELECTROCHEMICAL MACHINING
https://ir.sintx.com/news-events/press-releases/detail/209/sintx-technologies-awarded-phase-i-contract-from-the
SINTX TECHNOLOGIES AWARDED MULTI-YEAR DARPA CONTRACT TO DEVELOP CMCs AND HIGH TEMPERATURE COATINGS FOR TURBINE ENGINES
https://ir.sintx.com/news-events/press-releases/detail/207/sintx-technologies-awarded-multi-year-darpa-contract-to
SINTX TECHNOLOGIES AWARDED DEPARTMENT OF ENERGY GRANT FOR DEVELOPMENT OF 3D PRINTED CERAMIC HEAT EXCHANGERS
https://ir.sintx.com/news-events/press-releases/detail/202/sintx-technologies-awarded-department-of-energy-grant-for
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
List of Markets Sintx can participate in and products in development:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174489883
========================================
Sintx valuation should be greater than $230m based on comparable company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174491281
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
boston745
1 week ago
Before i get into Zimmer and Sintx, and not that i actually said Sintx would be acquired for $1+b, do you think Sintx IP could be worth north of a B based on addressable market size and several of its known/possible partner companies? It is worth over $230m based on comparable company and its material and its used $270m developing the tech. Public companies are generally worth more than their private counterparts and the ortho market has grown substantially since 2003. I would like to know what product is being worked on that Si3n4 can be used for Cancer treatments? Thats just 1 market that Si3n4 can play in that Implex Hydrocel couldnt.
List of Markets Sintx can participate in and products in development:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174489883
========================================
I didnt say conclusions were facts. The facts are someone posted Zimmer intends to acquire Sintx, then Amedica, for its tech and this was posted 3 years before Sintx went public so it was not an attempt to pump SINT/AMDA. Furthermore, mentions of Zimmer within Sintx IPO paperwork were removed indicating someone didnt want it widely known Sonny & previous chairman had ties to Zimmer. Since that time Zimmers actions have been consistent with this statement including being a strategic partner with Sintx testing its femoral head as evidence by the following verifiable evidence and hiring of a Si3N4 expert in Dr Lal.
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
Proof Zimmer Biomet is one of Sintx strategic partners:
Sintx 2016 10k
Together with a strategic partner, we have initiated biomechanical testing of our solid silicon nitride femoral heads. The results of this test will be released in 2017
This quote indicates the results of testing of their femoral head with a strategic partner will be released in 2017.
Those results were released testing Sintx Femoral head against Biomet's E1 liners. Thus Zimmer Biomet, or any of its subsidiaries, is Sintx strategic partner in this testing.
Amedica and Zimmer-Biomet (Tokyo Office) provided the femoral heads and acetabular liners; however, neither company actively sponsored the research
These are risk-averse companies that look to smaller companies like us to develop an idea, uh, and, uh, de-risk it, so to speak, and then buy that technology.
Dr Saurabh Lal, PHD (Si3N4 coatings expert)
Dr. Lal has never been directly connected to Sintx that im aware of. Hes included in this list because of his extensive Si3N4 work for European Unions Life Long Joints program for which Sintx has been a partner in. He serves as a Principle Engineer at Zimmer Biomet in Swindon, UK as part of its anti-infection coatings program. He was hired December 2018.
Quote Sources:
https://web.archive.org/web/20240408163612/https://spineblogger.blogspot.com/2011/05/whos-next.html?m=1
2016 10-k pg 13: https://www.sec.gov/Archives/edgar/data/1269026/000149315217010752/form10-k.htm
2017 results: https://ir.sintx.com/news-events/press-releases/detail/95/amedica-announces-results-of-independent-femoral-head-wear
https://web.archive.org/web/20240408152758/https://sintx.com/wp-content/uploads/2021/03/Investor-Call-Transcript-033021.pdf
https://www.researchgate.net/profile/Saurabh-Lal
========================================
Joe, you could have just posted this, but thank you for the link.
Rule 5815(d)(4)(A), entitled “Hearings Panel Monitor,” provides a Hearings Panel with
discretion to monitor a company for a period of up to one year after the date a company regains
compliance with a listing standard if it concludes that there is a likelihood that a company will
fail to maintain compliance with one or more listing standards during that period (including
requirements with which the company was not previously deficient). During this one-year
monitoring period, Staff will monitor the company, to confirm compliance with all listing
requirements. While Staff monitors all listed companies for compliance with the Exchange’s
listing standards, if Staff identifies a deficiency with any listing requirement for companies that
are being monitored under Rule 5815(d)(4)(A), staff may not provide the company with a cure or
compliance period, nor the opportunity to submit a plan to regain compliance with the
deficiency. Instead, Staff will issue a Delisting Determination for these companies.
As I already indicated, funds will want to keep SINT listed for liquidity purposes. Since they can only naked short so much, funds will need to keep SINT above 1 and have to look to profit more to the upside rather than downside.
https://www.sec.gov/files/rules/sro/nasdaq/2021/34-93789.pdf
joev2
1 week ago
Looks to me like Sint's game will finally expire. They have approximately 11 months to stay consistently over a buck. If we are to follow its history, once it goes under a dollar, it may have up to a week, bouncing above and below, before it's below for good. Boston is correct that management MUST get on board, even if only to feign interest. That in itself may not do the trick, though.
Truth is, this time if they stay under, they get delisted: no more freebies from nasdaq to play the shareholders. Wonder the timing of Bal's announcement? Stay tuned, folks. Looks like we'll finally see whether or not Sint can ACTUALLY get it going. I believe not, but we'll soon find out. They can always go private but what does that do for those that trusted this was a sound investment?
I'm sure at least one individual will still absolve management of all wrongdoing, but if correct, facts will once again prove that management at best WAS clueless in taking this public in the first place, and remained clueless throughout. Prove me wrong, Sonny.
joev2
1 week ago
All these conclusions you come to based on connecting dots (what you call facts) are YOUR OPINIONS ONLY, which is NOT supported by ANY investor of ANY category (you're free to consider those shorting every conclusion of yours, as a category). Obviously NOTHING is connecting as you envision and have envisioned for years (remember the billion dollar buyout?).
Haven't checked whether or not the following is actually factual or not, but I'm quite sure they're close! According to our very own IHUb, Sint is down from a high of $110,000 per share five years ago to $5 per share today. So you can enjoy all your subjective analysis all you want. No one but you is following it. THAT is a fact! Absolutely NO INVESTMENT FIRM, INSIDER or credible lending institution takes Sint for anything other than the joke that it is; hence it is left alone. Oh yes, fact is Maxim types LOVE the Sints of the world. Oh, and btw, thank you for the shared Info from the Nasdaq. Apparently, they're onto Bal and Sint as well. Good job, Nasdaq....sure took you long enough.
boston745
1 week ago
This is new and means things will have to be different going forward. Even more reason if there is going to be another offering, management needs to buy shares to help support the stock price. They cant just raise funds and let markets continue to naked short the stock. Is this a new thing being done by Nasdaq? This would also be another reason for 200:1 RS ratio over 100:1. BTW this is good news for investors, for the next year at least, as funds have incentive to keep this trading over 1 now!
The Company remains subject to a “Mandatory Panel Monitor,” as that term is defined in Listing Rule 5815(d)(4)(B), for a period of one year from June 11, 2024. If, within the one-year period, the Company fails to satisfy the minimum $1.00 closing bid price threshold for 30 consecutive business days, Nasdaq will issue a delist determination rather than provide the Company with a grace period to regain compliance with the Bid Price Rule. In that event, the Company would have the opportunity to request a new hearing to address the deficiency.
https://ir.sintx.com/news-events/press-releases/detail/232/sintx-technologies-regains-compliance-with-nasdaq-bid-price
=======================================
The purpose of disinformation Joe is the following:
Unlike misinformation, disinformation is false information that is designed to mislead others and is deliberately spread with the intent to manipulate truth and facts.
Unlike misinformation, though, the foundation of disinformation is malicious and deceptive.
I'd add that disinformation includes creating forum verbiage to drown out and distract from evidence. Purposeful attempts to move the debate from whatever important subject is being discussed and drown that out with personal attacks and tangent debates that have little to nothing to do with the core subject. Your posts continue to behave in such a manner. Personally id rather talk about Sintx than the disinformation techniques you continue to employ. In my next post i'll go more into what you brought up about Zimmer and Sintx.
joev2
1 week ago
Right and when you post 'motives' or 'aliases' or 'a working together' regarding others, that's not disinformation. When you state with certainty based on a subjective viewpoint that it's manipulation or a conspiracy because SOME individuals use common sense and short the crap out of this stock, that's not disinformation. Their only other choice in investing would be to 'buy' and do what you do, promote the company and it's so-called 'facts' while ignoring 'other facts' that show the company is run like a piece of crap. But hey, that's not disinformation or a conspiracy either.
And you know what? Maybe you're correct. Maybe it can't be a conspiracy (although it's still disinformation) because apparently, you're the ONLY individual who believes the crap you're spewing. As for the intentions of Zimmer, Bal, Sint and whomever, the fact that nothing of substance has EVER truly materialized, that's not a conspiracy or a working together either. Keep going. After all, as long as you can keep convincing yourself, you win! But (ahem), there's one problem....
boston745
1 week ago
Joe, theres the big difference between us. I post verifiable facts about the company and your posts continue to contain disinformation. Why is that?
TA I'm still not convinced you're not correct with the 'paid shill' comments. It's mind boggling to say the least, how one can STILL defend the indefensible viz management, without they themselves being part of the game plan
Method of disinformation: Question motives: Imply the opponent has questionable motives, such as a hidden agenda or other bias, putting them on the defensive.
https://www.ethosdebate.com/lies-rhetoric-4-18-rules-disinformation/
When one takes away the conspiracy notion (various alleged manipulations don't make a conspiracy, but they can show astute awareness to scammy-type operations) and 'bubbles'
First off manipulation by more than 1 party is the very definition of a conspiracy. Takes two or more parties working together, in agreement directly or indirect, for gain to indicate a conspiracy. You often downplay the notion of people working together shorting and distorting Sintx but there are multiple accounts spreading misinformation and employing disinformation techniques which falls under the label, 'Short and Distort'. Yet at the same time you directly, or indirectly, indicate im paid to post. Which would be a conspiracy between me and the company if true. Do you have evidence im compensated or you just employing disinformation techniques in your posts again? Meanwhile i can show multiple social media accounts posting misinformation and disinformation...including TAman87. If Sintx was a bad as those accounts claim they wouldnt need to resort to mis & disinformation.
Conspiracy comes from the Latin word conspiratio. While conspiratio can mean "plot" or "conspiracy", it can also be translated as "unity" and "agreement",
The following is fact and verifiable via the links below.
A basic roadmap laid out of Zimmer's intentions for Sintx back in 2011. This quote predates Sintx vast IP portfolio expansion. Any markets Zimmer Biomet does not currently participate in, that Sintx does, represents potential markets Zimmer Biomet can utilize Sintx to bolster its revenue through licensing as well as diversify those revenue sources.
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
Proof Zimmer Biomet is one of Sintx strategic partners:
Sintx 2016 10k
Together with a strategic partner, we have initiated biomechanical testing of our solid silicon nitride femoral heads. The results of this test will be released in 2017
This quote indicates the results of testing of their femoral head with a strategic partner will be released in 2017.
Those results were released testing Sintx Femoral head against Biomet's E1 liners. Thus Zimmer Biomet, or any of its subsidiaries, is Sintx strategic partner in this testing.
Amedica and Zimmer-Biomet (Tokyo Office) provided the femoral heads and acetabular liners; however, neither company actively sponsored the research
These are risk-averse companies that look to smaller companies like us to develop an idea, uh, and, uh, de-risk it, so to speak, and then buy that technology.
Quote Sources:
https://web.archive.org/web/20240408163612/https://spineblogger.blogspot.com/2011/05/whos-next.html?m=1
2016 10-k pg 13: https://www.sec.gov/Archives/edgar/data/1269026/000149315217010752/form10-k.htm
2017 results: https://ir.sintx.com/news-events/press-releases/detail/95/amedica-announces-results-of-independent-femoral-head-wear
https://web.archive.org/web/20240408152758/https://sintx.com/wp-content/uploads/2021/03/Investor-Call-Transcript-033021.pdf
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
List of Markets Sintx can participate in and products in development:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174489883
========================================
Sintx valuation should be greater than $230m based on comparable company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174491281
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Monksdream
6 days ago
Hot Features
Premium
